Context Therapeutics (CNTX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.24, -5.86% vs the prior close of $0.26.
- Volume 1.34M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CNTX slides 5.9% to $0.24, a 52-week low, 3 down days in a row. Closed at $0.24, -5.86% vs the prior close of $0.26. Day range $0.24–$0.27, opened at $0.25.
CNTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CNTX slides 5.9% to $0.24, a 52-week low, 3 down days in a row
- Closed at $0.24, -5.86% vs the prior close of $0.26. Day range $0.24–$0.27, opened at $0.25.
- Volume was 1.34M shares, 0.8x its 50-day average of 1.60M.
- Price is -37.6% vs its 50-day average ($0.39) and -84.2% vs its 200-day average ($1.53).
- 52-week range $0.24–$3.62; today's close sits at 0% of that range, 93.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — CNTX slides 6.9% to $0.26, a 52-week low
- Closed at $0.26, -6.91% vs the prior close of $0.28. Day range $0.25–$0.27, opened at $0.27.
- Volume was 960.60K shares, 0.6x its 50-day average of 1.60M.
- Price is -35.2% vs its 50-day average ($0.39) and -83.3% vs its 200-day average ($1.53).
- 52-week range $0.25–$3.62; today's close sits at 0% of that range, 92.9% below the 52-week high.
Oct 13, 2026 — CNTX slides 9.8% to $0.28, a 52-week low
- Closed at $0.28, -9.84% vs the prior close of $0.31. Day range $0.27–$0.31, opened at $0.30.
- Volume was 1.25M shares, 0.8x its 50-day average of 1.60M.
- Price is -31.6% vs its 50-day average ($0.40) and -82.1% vs its 200-day average ($1.54).
- 52-week range $0.27–$3.62; today's close sits at 0% of that range, 92.4% below the 52-week high.
Oct 12, 2026 — CNTX rises 0.3% to $0.31
- Closed at $0.31, +0.33% vs the prior close of $0.30. Day range $0.29–$0.31, opened at $0.29.
- Volume was 503.30K shares, 0.3x its 50-day average of 1.61M — lighter than usual.
- Price is -25.4% vs its 50-day average ($0.41) and -80.2% vs its 200-day average ($1.54).
- 52-week range $0.29–$3.62; today's close sits at 0% of that range, 91.6% below the 52-week high.
Oct 9, 2026 — CNTX rises 1.7% to $0.30
- Closed at $0.30, +1.67% vs the prior close of $0.30. Day range $0.30–$0.31, opened at $0.30.
- Volume was 588.70K shares, 0.4x its 50-day average of 1.62M — lighter than usual.
- Price is -26.7% vs its 50-day average ($0.41) and -80.3% vs its 200-day average ($1.55).
- 52-week range $0.29–$3.62; today's close sits at 0% of that range, 91.6% below the 52-week high.
Oct 8, 2026 — CNTX slides 4.5% to $0.30, a 52-week low, 3 down days in a row
- Closed at $0.30, -4.47% vs the prior close of $0.31. Day range $0.29–$0.32, opened at $0.31.
- Volume was 916.60K shares, 0.6x its 50-day average of 1.62M — lighter than usual.
- Price is -29.0% vs its 50-day average ($0.42) and -80.7% vs its 200-day average ($1.55).
- 52-week range $0.29–$3.62; today's close sits at 0% of that range, 91.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CNTX dips 2.8% to $0.31
- Closed at $0.31, -2.80% vs the prior close of $0.32. Day range $0.31–$0.32, opened at $0.32.
- Volume was 464.20K shares, 0.3x its 50-day average of 1.66M — lighter than usual.
- Price is -26.7% vs its 50-day average ($0.43) and -79.9% vs its 200-day average ($1.56).
- 52-week range $0.30–$3.62; today's close sits at 0% of that range, 91.4% below the 52-week high.
Oct 6, 2026 — CNTX slides 4.5% to $0.32
- Closed at $0.32, -4.45% vs the prior close of $0.34. Day range $0.32–$0.36, opened at $0.34.
- Volume was 898.70K shares, 0.5x its 50-day average of 1.68M — lighter than usual.
- Price is -25.6% vs its 50-day average ($0.43) and -79.4% vs its 200-day average ($1.56).
- 52-week range $0.30–$3.62; today's close sits at 1% of that range, 91.1% below the 52-week high.
Oct 5, 2026 — CNTX jumps 8.7% to $0.34
- Closed at $0.34, +8.71% vs the prior close of $0.31. Day range $0.31–$0.34, opened at $0.31.
- Volume was 1.00M shares, 0.6x its 50-day average of 1.70M — lighter than usual.
- Price is -23.2% vs its 50-day average ($0.44) and -78.5% vs its 200-day average ($1.56).
- 52-week range $0.30–$3.62; today's close sits at 1% of that range, 90.7% below the 52-week high.
Oct 2, 2026 — CNTX dips 1.3% to $0.31
- Closed at $0.31, -1.27% vs the prior close of $0.31. Day range $0.30–$0.32, opened at $0.31.
- Volume was 329.20K shares, 0.2x its 50-day average of 1.72M — lighter than usual.
- Price is -30.2% vs its 50-day average ($0.44) and -80.2% vs its 200-day average ($1.57).
- 52-week range $0.30–$3.62; today's close sits at 0% of that range, 91.4% below the 52-week high.
CNTX latest news & SEC filings
Every SEC filing by or about CNTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$14.56M (prior year -$8.83M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.15 (prior year -$0.09) (loss widened vs Jun 30, 2025)
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade CNTX
- Last results release: Mar 22, 2023 (8-K Item 2.02). Previous ones: Mar 23, 2022, Dec 2, 2021. Based on that rhythm, the next report is likely around Jun 21, 2023 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.29% (largest 9.8%). That is a volatile stock.
- Liquidity: about 940.82K shares (≈$226.74K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.24 vs a range of $0.24–$3.62 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 5, 2026; 10-Q Aug 5, 2026; 8-K Jul 31, 2026.
- Share count: 91.88M shares outstanding (Aug 3, 2026), +2.4% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CNTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.25 | 0.27 | 0.24 | 0.24 | 1.34M |
| Oct 14, 2026 | 0.27 | 0.27 | 0.25 | 0.26 | 960.60K |
| Oct 13, 2026 | 0.30 | 0.31 | 0.27 | 0.28 | 1.25M |
| Oct 12, 2026 | 0.29 | 0.31 | 0.29 | 0.31 | 503.30K |
| Oct 9, 2026 | 0.30 | 0.31 | 0.30 | 0.30 | 588.70K |
| Oct 8, 2026 | 0.31 | 0.32 | 0.29 | 0.30 | 916.60K |
| Oct 7, 2026 | 0.32 | 0.32 | 0.31 | 0.31 | 464.20K |
| Oct 6, 2026 | 0.34 | 0.36 | 0.32 | 0.32 | 898.70K |
| Oct 5, 2026 | 0.31 | 0.34 | 0.31 | 0.34 | 1.00M |
| Oct 2, 2026 | 0.31 | 0.32 | 0.30 | 0.31 | 329.20K |
| Oct 1, 2026 | 0.31 | 0.32 | 0.30 | 0.31 | 1.14M |
| Sep 30, 2026 | 0.33 | 0.33 | 0.30 | 0.30 | 1.19M |
| Sep 29, 2026 | 0.32 | 0.33 | 0.31 | 0.32 | 849.40K |
| Sep 28, 2026 | 0.35 | 0.35 | 0.32 | 0.33 | 1.55M |
| Sep 25, 2026 | 0.37 | 0.38 | 0.34 | 0.35 | 1.32M |
| Sep 24, 2026 | 0.38 | 0.39 | 0.36 | 0.37 | 880.20K |
| Sep 23, 2026 | 0.39 | 0.40 | 0.37 | 0.38 | 1.11M |
| Sep 22, 2026 | 0.39 | 0.40 | 0.37 | 0.39 | 539.00K |
| Sep 21, 2026 | 0.38 | 0.39 | 0.36 | 0.38 | 770.20K |
| Sep 18, 2026 | 0.39 | 0.40 | 0.37 | 0.37 | 1.21M |
About Context Therapeutics
Context Therapeutics (CNTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in PHILADELPHIA, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1842952.
CNTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Philip W. Kantoff | Director | Jun 26, 2026 |
| Martin A. Lehr | Chief Executive Officer | Feb 23, 2026 |
| Andy Pasternak | Director | Jun 26, 2026 |
| Karen L. Smith | Director | Jun 26, 2026 |
| Jennifer Evans Stacey | Director | Jun 26, 2026 |
| Luke Nathaniel Walker | Director | Jun 26, 2026 |
| Linda West | Director | Jun 26, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Karen Deborah Chagin | Chief Medical Officer | Feb 23, 2026 |
| Martin A. Lehr | Chief Executive Officer | Feb 23, 2026 |
| Alex C. Levit | Chief Legal Officer, Corp. Sec | Feb 23, 2026 |
| Jennifer Lynn Minai-Azary | Chief Financial Officer | Feb 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CNTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-36.12M | -0.38 | $-26.39M |
| Dec 31, 2024 | — | $-26.73M | -0.46 | $-14.56M |
| Dec 31, 2023 | — | $-23.96M | -1.50 | $-21.05M |
| Dec 31, 2022 | — | $-14.84M | -0.93 | $-13.55M |
| Dec 31, 2021 | — | $-10.46M | -3.69 | $-8.80M |
Latest balance sheet: total assets $46.13M, total liabilities $7.96M, cash $42.99M (as of Jun 30, 2026).
CNTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 22, 2023 | 8-K Item 2.02 (results) | — |
| Mar 23, 2022 | 8-K Item 2.02 (results) | — |
| Dec 2, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CNTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.